 |
 |
      |
|
 |
Ventria Bioscience is uniquely positioned to become a scientific leader in the biopharmaceutical industry. We are dedicated to developing and producing innovative, high value products that enhance and save lives. We have achieved scientific excellence through internal research and development and collaborations with world-renowned biotech and industry leaders. Together we have created a rich product pipeline with innovative products in human nutrition and human therapeutics. The market for these products exceeds $2 billion annually. In 1997, Ventria's scientists developed a breakthrough protein
expression technology with unrivaled efficiency. This proprietary
technology platform is called ExpressTec. ExpressTec's cost-efficiency
and proven commercial scalability make it possible for Ventria to
address unmet and underserved needs in human and animal health by
delivering affordable treatments on a global scale.
|
|
||||||||||||||
 |
|
